These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7603351)

  • 21. Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection.
    Christmas SE; Halliday D; Lawton N; Wang H; Abdalla I; Masters J; Hassan RL; Hart IJ; Khan N; Smith J; Hammad A; Bakran A
    Transpl Immunol; 2009 Dec; 22(1-2):99-104. PubMed ID: 19635559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy.
    Eggers M; Radsak K; Enders G; Reschke M
    J Med Virol; 2001 Feb; 63(2):135-42. PubMed ID: 11170050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M; Styczyński P
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.
    Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S
    J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM.
    Lazzarotto T; Ripalti A; Bergamini G; Battista MC; Spezzacatena P; Campanini F; Pradelli P; Varani S; Gabrielli L; Maine GT; Landini MP
    J Clin Microbiol; 1998 Nov; 36(11):3337-41. PubMed ID: 9774589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus antibodies in renal transplant recipients.
    Jankowski M; Gut W; Nawrocka E; Gradowska L; Roncewicz Z; Rowińska D
    Acta Microbiol Pol; 1982; 31(3-4):279-85. PubMed ID: 6189377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.
    Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
    In Vivo; 2002; 16(3):153-9. PubMed ID: 12182109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prokaryotic expression of a large fragment of the most antigenic cytomegalovirus DNA-binding protein (ppUL44) and its reactivity with human antibodies.
    Ripalti A; Dal Monte P; Boccuni MC; Campanini F; Lazzarotto T; Campisi B; Ruan Q; Landini MP
    J Virol Methods; 1994 Jan; 46(1):39-50. PubMed ID: 8175946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.
    Gibson L; Dooley S; Trzmielina S; Somasundaran M; Fisher D; Revello MG; Luzuriaga K
    J Infect Dis; 2007 Jun; 195(12):1789-98. PubMed ID: 17492595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice.
    Gallez-Hawkins G; Li X; Franck AE; Thao L; Lacey SF; Diamond DJ; Zaia JA
    Vaccine; 2004 Dec; 23(6):819-26. PubMed ID: 15542207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
    Eichler C; Kaden J; May G
    Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope mapping of mouse monoclonal antibodies to the ppUL83 lower matrix phosphoprotein of human cytomegalovirus.
    Zal B; Booth J; Chadwick J; Baboonian C
    J Med Virol; 1999 Mar; 57(3):290-7. PubMed ID: 10022802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene cloning of the human cytomegalovirus (HCMV) antigen reactive with the serum from a HCMV-infected patient.
    Kim MN; Park CG; Hwang ES; Lim DG; Park JW; Seoh JY; Kook YH; Lee HJ; Choi SB; Cha CY
    J Korean Med Sci; 1994 Dec; 9(6):476-81. PubMed ID: 7786444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to human cytomegalovirus structural polypeptides during primary infection.
    Landini MP; Rossier E; Schmitz H
    J Virol Methods; 1988 Dec; 22(2-3):309-17. PubMed ID: 2851606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
    Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B
    J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody responses to synthetic peptides from cytomegalovirus phosphoprotein 150.
    Sundqvist VA; Xu W; Wahren B
    J Clin Microbiol; 1992 Oct; 30(10):2735-9. PubMed ID: 1328283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern and persistence of the epitope-specific IgM response against human cytomegalovirus in renal transplant patients.
    Müller TF; Gicklhorn D; Jungraithmayr T; Eickmann M; Lange H; Radsak K; Reschke M
    J Clin Virol; 2002 Feb; 24(1-2):45-56. PubMed ID: 11744428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody response to individual cytomegalovirus structural proteins in different groups of subjects.
    Mirolo G; Baldassarri B; Ripalti A; Re MC; Clementi M; Manzin A; Landini MP
    Eur J Clin Microbiol; 1987 Apr; 6(2):207-10. PubMed ID: 3036503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.